WeedMD (TSXV:WMD) obtained an amendment approval to its federal cannabis license to expand production into six additional 10,000 square foot cultivation rooms for its greenhouse facility in Ontario.
As quoted in the press release:
Licensing of the six additional grow rooms, comprising a total of 60,000 [square feet], increases WeedMD’s licensed production space in Strathroy to 110,000 sq. ft. and increases the Company’s total production footprint, including its indoor cultivation centre-of-excellence in Aylmer, Ontario, to 136,000 [square feet].
“This is an exciting time for WeedMD – we have just completed another amazing round of cannabis harvests from our two sites and we are now able to capitalize on our large-production greenhouse capacity expansion,” said Keith Merker, CEO of WeedMD. “We have been busy preparing for this pivotal moment and have more than 20,000 cannabis plants that we will begin transplanting into the new rooms immediately. With a total of 10 cultivation rooms now in operation at our state-of-the-art greenhouse, we are responding to the considerable demand for cannabis with an efficient production ramp up in order to meet supply commitments to our patients, provincial partners, seniors care providers, Shoppers Drug Mart, and a growing number of new patients and customers across the country. Additionally, we’re on the cusp of completing the fully-funded retrofit of our hybrid greenhouse expected to yield high-quality, cost-effective cannabis cultivation in 2019.”